丹红注射液联合地尔硫卓治疗冠心病不稳定性心绞痛疗效分析

Curative observation in treatment of unstable angina pectoris with danhong injection and diltiazem

目的观察丹红注射液联合地尔硫卓治疗冠心病不稳定性心绞痛的疗效。方法将76例冠心病不稳定性心绞痛患者分为常规治疗加用丹红注射液治疗组39例(治疗组)和常规治疗组37例(对照组)。结果治疗组心绞痛、心电图疗效优于对照组(P<0.05)。治疗组治疗后血浆黏度和纤维蛋白原均低于对照组(P<0.05)。结论与常规治疗相比,加用丹红注射液联合地尔硫卓治疗冠心病不稳定性心绞痛有较好的疗效。

Objective To evaluate the curative effects of danhong injection combined with diltiazem in the treatment of unstable angina pectoris. Methods In accordance with the diagnostic criteria, 76 patients were selected and then divided into a routine treatment group with 37 cases （control group） and a routine treatment plus danhong injection and diltiazem group with 39 cases （treatment group）. Results The improvements of angina and ECG in the treatment group were better than those in the control group, P 〈 0.05. The whole blood viscodty and fibrous proteinogen levels in the treatment group were lower than those in the control group, P 〈 0.05. Conclusions The extra treatment of unstable angina pectoris with danhong injection and diltiazem has better curative effects, compared with the routine treatment.